Literature DB >> 17786489

Molecular dynamics studies on HIV-1 protease: a comparison of the flap motions between wild type protease and the M46I/G51D double mutant.

Antonino Lauria1, Mario Ippolito, Anna Maria Almerico.   

Abstract

The emergence of drug-resistant mutants of HIV-1 is a tragic effect associated with conventional long-treatment therapies against acquired immunodeficiency syndrome. These mutations frequently involve the aspartic protease encoded by the virus; knowledge of the molecular mechanisms underlying the conformational changes of HIV-1 protease mutants may be useful in developing more effective and longer lasting treatment regimes. The flap regions of the protease are the target of a particular type of mutations occurring far from the active site. These mutations modify the affinity for both substrate and ligands, thus conferring resistance. In this work, molecular dynamics simulations were performed on a native wild type HIV-1 protease and on the drug-resistant M46I/G51D double mutant. The simulation was carried out for a time of 3.5 ns using the GROMOS96 force field, with implementation of the SPC216 explicit solvation model. The results show that the flaps may exist in an ensemble of conformations between a "closed" and an "open" conformation. The behaviour of the flap tips during simulations is different between the native enzyme and the mutant. The mutation pattern leads to stabilization of the flaps in a semi-open configuration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786489     DOI: 10.1007/s00894-007-0242-3

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  18 in total

1.  Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.

Authors:  Hiroyasu Ohtaka; Arne Schön; Ernesto Freire
Journal:  Biochemistry       Date:  2003-11-25       Impact factor: 3.162

2.  A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6.

Authors:  Chris Oostenbrink; Alessandra Villa; Alan E Mark; Wilfred F van Gunsteren
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  Insights into amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free-energy calculations.

Authors:  Heike Meiselbach; Anselm H C Horn; Thomas Harrer; Heinrich Sticht
Journal:  J Mol Model       Date:  2006-06-23       Impact factor: 1.810

Review 4.  HIV protease: a novel chemotherapeutic target for AIDS.

Authors:  J R Huff
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

5.  Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex.

Authors:  B Maschera; G Darby; G Palú; L L Wright; M Tisdale; R Myers; E D Blair; E S Furfine
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

6.  Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.

Authors:  S Seelmeier; H Schmidt; V Turk; K von der Helm
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.

Authors:  W R Scott; C A Schiffer
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

8.  Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.

Authors:  Thomas D Wu; Celia A Schiffer; Matthew J Gonzales; Jonathan Taylor; Rami Kantor; Sunwen Chou; Dennis Israelski; Andrew R Zolopa; W Jeffrey Fessel; Robert W Shafer
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Flap opening dynamics in HIV-1 protease explored with a coarse-grained model.

Authors:  Valentina Tozzini; Joanna Trylska; Chia-en Chang; J Andrew McCammon
Journal:  J Struct Biol       Date:  2006-08-23       Impact factor: 2.867

10.  Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.

Authors:  Marek Ingr; Tat'ána Uhlíková; Kvido Strísovský; Eva Majerová; Jan Konvalinka
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

View more
  2 in total

1.  Atomistic simulations of the HIV-1 protease folding inhibition.

Authors:  Gennady Verkhivker; Guido Tiana; Carlo Camilloni; Davide Provasi; Ricardo A Broglia
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

2.  Drug-resistant molecular mechanism of CRF01_AE HIV-1 protease due to V82F mutation.

Authors:  Xiaoqing Liu; Zhilong Xiu; Ce Hao
Journal:  J Comput Aided Mol Des       Date:  2009-02-15       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.